Healthcare Triangle has signed a nonbinding letter of intent to acquire certain intellectual property, trademarks, customer contracts, and business assets associated with Roboticom for up to $30 million in cash and equity. The proposed transaction would expand the Pleasanton, California-based healthcare technology company’s operations into industrial robotics and precision automation, potentially combining its existing artificial intelligence, cloud, and data capabilities with Roboticom’s industrial automation technology.
The agreement was signed with Crestpoint Capital LLC, which is identified as the seller. If completed, Healthcare Triangle would acquire the specified assets associated with Roboticom, a Pisa, Italy-based provider of robotic automation systems for precision surface treatment.
Roboticom’s technology is marketed under its SandRob, ORTIS, and ScultoRob product lines, which serve customers across aerospace, marine, composites, orthotics and prosthetics, automotive, advanced manufacturing, and industrial tooling.
The company’s systems are designed to automate specialized manufacturing processes that require precision, consistency, and repeatability.
Healthcare Triangle believes the proposed transaction could provide an opportunity to extend its technology platform beyond healthcare into industrial automation and advanced manufacturing.
The company also sees potential to integrate its AI capabilities with Roboticom’s established robotics technology as manufacturers increasingly evaluate automation solutions.
According to unaudited information provided by Roboticom’s current ownership group, the business generated approximately $14.1 million in revenue and $6.9 million in gross margin during fiscal 2025. The ownership group also reported that the business was EBITDA-positive during the period.
These figures have not been independently verified by Healthcare Triangle and remain subject to confirmation through the company’s due diligence process.
Roboticom management has also prepared a five-year Growth and Operating Plan that targets $153.5 million in revenue and $64 million in adjusted operating contribution by fiscal 2029/30.
However, those figures are management projections rather than independently verified forecasts. Healthcare Triangle has explicitly stated that it is not adopting or endorsing the projections.
The adjusted operating contribution measure is non-GAAP, has not been reconciled to the most directly comparable GAAP measure, and may not be comparable to similarly named financial measures used by other companies.
The projections depend on significant assumptions, and actual financial results could differ materially.
Under the proposed transaction structure, Healthcare Triangle would acquire 100% of the specified customer contracts, intellectual property, trademarks, and business assets for consideration of up to $30 million, payable through a combination of cash and equity over time.
The transaction would not necessarily involve acquiring the entire legal entity associated with Roboticom.
According to publicly available information cited in the announcement, Roboticom is a brand of Fabrica Machinale Srl, an Epica International company, based in Navacchio di Cascina near Pisa, Italy. It also maintains a commercial presence in Landrum, South Carolina.
Its technology portfolio includes the ARPP software platform alongside its robotic automation systems.
Healthcare Triangle will need to confirm the seller’s legal ownership of the assets covered by the proposed transaction as part of its due diligence.
Additional requirements include completing an audit of the target business’s financial statements, securing acquisition financing, obtaining required approvals, and negotiating definitive transaction agreements.
The proposed acquisition would represent a strategic expansion for Healthcare Triangle, which currently provides technology services to hospitals, health systems, healthcare payers, pharmaceutical companies, and life sciences organizations.
Its existing offerings include cloud infrastructure, data management, and AI-related technology designed to help healthcare organizations improve their use of information systems.
The company’s Cloud and Data Platform, marketed through CloudEz and DataEz, has achieved HITRUST Risk-based, two-year Certified status.
Healthcare Triangle believes its experience with cloud and data infrastructure could complement Roboticom’s industrial automation platform, although specific integration plans have not been disclosed.
The letter of intent also references the possibility of a future spin-off or public listing. However, no such transaction has been agreed upon, and the company has not committed to pursuing one.
The acquisition remains proposed rather than completed. The letter of intent is nonbinding, and there is no assurance that the parties will enter into a definitive agreement or complete the transaction.
KEY QUOTE:
“I believe this could represent a significant opportunity for HCTI. I am pleased to explore entering the robotics space and the prospect of combining our AI technology with this business to enhance its competitive positioning.”
David Ayanoglou, Chief Financial Officer of Healthcare Triangle
